Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more Herceptin biosimilars can’t make Perjeta cost effective, says NICE. NICE has once again rejected Roche’s HER2-positive breast cancer drug Perjeta for treating patients after surgery in those who ... The Institute had already rejected it in this

ABPI hits out at ‘punitive’ UK medicines cost controls

ABPI hits out at ‘punitive’ UK medicines cost controls set a target of £300m in savings from biosimilars in the next three years – led by cheaper versions of drugs such as Herceptin, MabThera and Humira – but Warwick Smith says the

Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar and Xeljanz

Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar and Xeljanz Will Pfizer spark price war with its Herceptin biosimilar? Eclipsed, but still growing: Opdivo approved in new melanoma setting. ... Tajekesa Chapman, PhD, Pharma Analyst at GlobalData says Herceptin had sales of $2.2bn last year, despite its European

Amgen’s R&D chief Sean Harper retires to seek biotech post

Amgen’s R&D chief Sean Harper retires to seek biotech post of Amgen’s first biosimilar Kanjinti, a version of Roche’s breast cancer blockbuster Herceptin (trastuzumab).

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down More biosimilar erosion in Europe is close at hand, however: 2018 will see the decline in Herceptin (-5% this quarter) and Avastin (-2%) accelerate.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics